2021-01-25 16:57 pm
hPSC-based Regenerative Medicine by Innovative Technology Completely Overcoming Tumorigenicity
Platform technology with high through put design and development of tumorigenic cell-targeting lentiviral vector (TC-LV), and producing master cells